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Seven monoclonal antibodies were raised against the 
immunoglobulin-like extracellular domain of PO (PO-
ED), the major protein of peripheral nervous system 
myelin. Mice were immunized with purified recom-
binant rat PO-ED. After fusion, 7 clones (POI-P07) 
recognizing either recombinant, rat, mouse, or hu-
man PO-ED were selected by ELlS A and were char-
acterized by Western blot, immunohistochemistry, 
and a competition assay. Antibodies belonged to the 
IgG or IgM class, and P04-P07, reacted with PO in 
fresh-frozen and paraffin-embedded sections of hu-
man or rat peripheral nerve, but not with myelin 
proteins of the central nervous system of either spe-
cies. Epitope specificity of the antibodies was deter-
mined by a competition enzyme-linked immunosor-
bent assay (ELISA) and a direct ELlS A using short 
synthetic peptides spanning the entire extracellular 
domain of PO. These assays showed that POl and P02 
exhibiting the same reaction pattern in Western blot 
and immunohistochemistry reacted with different 
distant epitopes of PO. Furthermore, the monoclonal 
antibodies P05 and P06 recognized 2 different 
epitopes in close proximity within the neuritogenic 
extracellular sequence of PO. This panel of mono-
clonal antibodies, each binding to a different epitope 
of the extracellular domain of PO, will be useful for in 
vitro and in vivo studies designed to explore the role 
of PO during myelination and in demyelinating dis-
eases of the peripheral nervous system. 
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INTRODUCTION 
The glycoprotein PO accounts for over 50% of the 
protein present in purified peripheral myelin (Greenfield 
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et al., 1973; Ishaque et al., 1980). PO is a member of the 
immunoglobulin superfamily containing one V-like im-
munoglobulin domain (Williams and Barcley, 1988) and 
has an apparent molecular mass of 28-30 kD. It is pro-
duced exclusively by myelinating Schwann cells (Trapp 
et a!., 1987; Martini et a!., 1988). 
Recently it has been shown that the extracellular 
domain of PO (PO-ED) acts as a homotypic adhesion 
molecule and has neurite outgrowth-promoting proper-
ties (Fi1bin et a!., 1990; Schneider-Schaulies et a!., 1990; 
D'Urso et a!., 1990; Filbin and Tennekoon, 1991). Be-
cause of these properties PO could be important for the 
initiation of myelination and the maintenance of compact 
myelin in the peripheral nervous system (Lemke et a!., 
1988). 
Furthermore, there is evidence to suggest that PO 
may be involved in the pathogenesis of demyelinating 
diseases of the PNS: (1) In some demyelinating polyneu-
ropathies associated with a monoclonal gammopathy, 
high titers of anti-PO antibody are found which recognize 
mainly carbohydrate determinants on PO (Bollensen et 
a!., 1987; Burger et a!., 1990). (2) Antibodies to PO can 
produce demyelination when injected into rat sciatic 
nerves (Hughes et a!., 1985; Hosokawa et a!., 1990). 
However, direct experimental evidence for a demyelinat-
ing role of antibodies to PO in human neuropathies is still 
lacking (for review see Hartung et a!., 1993). (3) PO has 
also been described to induce experimental autoimmune 
("allergic") neuritis (EAN) in rats (Milner et a!., 1987). 
Recent experiments with the adoptive transfer model of 
EAN showed that one neuritogenic T -cell epitope is lo-
cated within the amino acid sequence 56-71 of the ex-
tracellular domain of PO (Linington et a!., 1992). (4) In 
some patients with GBS, T cells reactive with human PO 
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have been identified early in the disease course (Khalili-
Shirazi et aI., 1992). 
Monoclonal antibodies recognizing extracellular 
epitopes with known amino acid sequences of PO would 
be useful tools for in-vivo immunomodulation experi-
ments and may thus help to define the precise role of PO 
during demyelinating diseases. Therefore, we used the 
recombinant extracellular domain of PO to establish a 
panel of monoclonal antibodies recognizing rat and hu-
man PO. 
MATERIALS AND METHODS 
Expression and Purification of Recombinant PO-ED 
The PO-EO construct contained the 124 amino acid 
residues (amino acids 1-124) from the extracellular do-
main of rat PO and a total of 20 amino acid residues from 
the pET3 expression vector system (Rosenberg et al., 
1987). Expression of the 17.1 kO recombinant Ig-like 
PO-EO was carried out with as previously described 
(Schneider-Schaulies et aI., 1990). 
In brief, 100 ml of an overnight culture of bacteria 
[BL21(OE3)] containing plasmid pET3-PO-EO were 
added to 900 ml Luria-broth medium (Gibco, Karlsruhe, 
Germany) and were induced at 37°C with 1 mM isopro-
pylthio-I3-0-galactoside (IPTG) for 6 hr to express high 
levels of recombinant PO-EO. PO-EO expressing bacte-
rial cultures (l,000 ml) were centrifuged at 4°C and 
3,000 g for 20 min and lysed by 4 cycles of freeze-
thawing (liquid nitrogen/37°C) and centrifuged at 32,000 
g for 30 min to isolate the insoluble PO-EO in the form of 
inclusion bodies. The insoluble bacterial pellet was in-
cubated twice overnight at 4°C with 25 ml extraction 
buffer (4 M urea, 50 mM Tris-HCI, pH 8.0). A crude 
lysate from 1,000 ml of a bacterial culture contained 
approximately 10 mg PO-EO protein as determined by 
SOS-PAGE. To purify PO-EO, the protein extract was 
size-fractioned twice on a Sephadex G-50 column using 
4 M urea in Tris-HCI pH 8.0 as a running buffer. 
The PO-EO containing fractions were collected and 
concentrated by pressure filtration through Amicon fil-
ters (PM 10, Witten, Germany) to give a final protein 
concentration of 2.5 mg/ml. The fraction was denatured 
at room temperature with dithioerythritol (OTE, 50 mg/ 
ml), 6 M guanidinium . HCI, 100 mM Tris-HCI, pH 8.0, 
and reoxidized for 24 hr by 5 mM oxidized glutathione 
(Calbiochem, Bad Soden, Germany) in lOO-fold excess 
volume to allow refolding of the molecule. After this 
renaturation procedure, PO-EO remained soluble in phys-
iological buffers. SOS-PAGE using 15% acrylamide slab 
gels revealed I major band at 17 kO. 
Immunization and Fusion 
Balb/C mice (female, 6 weeks old, obtained from 
Zentralinstitut fUr Versuchstierzucht, Hannover, Ger-
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many) were primed with an intraperitoneal injection of 
50 j.Lg PO-EO in complete Freund's adjuvant (Oifco, De-
troit, Michigan) and boosted 5 times, at an interval of 
6-8 weeks each, with 20 j.Lg PO-EO in incomplete Fre-
und's adjuvant until serum titers reached levels greater 
1 :50,000 in the enzyme-linked immunosorbent assay 
(ELISA). The Balb/C mice, known to be resistant to 
neuritogenic antigens, did not develop clinical signs of 
acute experimental autoimmune neuritis after immuniza-
tion with PO-EO (data not shown). 
Three days after the last injection, spleen cells were 
fused with the mouse myeloma cell line Ag8-653 ob-
tained from the American Type Tissue Collection (Rock-
ville, MD). The fused cells were distributed over ten 
96-well microtiter plates (Nunc, Wiesbaden, Germany). 
Hybridoma cells were grown using standard methods, 
and supernatants were screened for the presence of an-
tibodies directed against PO-EO by ELISA as described 
below. Hybridoma cells selected on the basis of the re-
sults in this ELISA were cloned by limiting dilution and 
direct picking of the clones from the plates. 
ELISA 
Ninety-six-well microtiter plates were coated with 
4 j.Lg/ml PO-EO in 0.1 M NaHC03 pH 9.6 at 4°C over-
night and blocked with 0.5% bovine serum albumin 
(BSA) in phosphate-buffered saline (PBS). Plates were 
washed several times with 200 j.Lllwell PBS, containing 
0.1 % Tween 20, and incubated with hybridoma super-
natant for 30 min on a rotary shaker at 300 rpm. After a 
second washing, plates were incubated for 30 min with 
horseradish peroxidase-coupled goat-anti-mouse immu-
noglobulin (Boehringer, Mannheim, Germany; diluted 
1:500 in blocking buffer). Antibody binding was visual-
ized by using 2 mM ABTS [2,2' -azino-bis(3-ethylbenz-
thiazoline-6-sulfonic acid); Boehringer, Mannheim] in 
0.1 M acetate buffer, pH 4.2, and 2.5 mM hydrogen 
peroxide. Optical density (0.0.) was recorded at wave-
lengths of 405 and 495 nm with an ELISA reader. 
Positive supernatants were also tested on reactivity 
to rat PO measured in an direct ELISA. For this purpose 
20 j.Lg of rat myelin (vide infra) were included in the 
coating buffer containing 0.2% SOS. The plates were 
then processed as described above for PO-EO. 
Competition and Direct ELISA With 
Synthetic Peptides 
To investigate whether the monoclonal antibodies 
bound to independent epitopes of the extracellular do-
main of PO, the metpod of Friguet et al. (1983) was used 
in the ELISA system described above. Since only im-
munoglobulins of the same class could be tested with this 
method, P03 (IgG3) and P07 (IgGl) had to be excluded 
from this assay. Only IgMs with the same reaction pat-
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terns in Western blot and immunohistochemistry were 
included. In brief, 2 different monoclonal antibodies of 
the same Ig subclass were added, either together or 
alone, into each well of microtiter p!ates coated with a 
relatively low amount of antigen (0.1 f-Lg PO-EO/ml, 50 
f-LlIwell). 
For this purpose culture supernatants of both tested 
antibodies were diluted with medium until each super-
natant gave a similar absorbance in the PO-EO ELISA 
(described above) but were still concentrated enough to 
saturate the low amounts of coated PO-EO, as estimated 
by using different concentrations of the diluted superna-
tant. This resulted in nearly complete saturation of the 
epitope recognized by each antibody. If 2 antibodies 
were added together into one well, then after develop-
ment with ABTS (see above), binding of antibodies to 
different epitopes yielded an increase of the measured 
0.0. at 405 nm compared to the values detected if only 
one antibody was added to the well. 
Binding to the same or a nearby epitope did not 
result in an increased 0.0. value if compared to the 
individual values. Similarly, the amount of antibody 
bound was assumed to be proportional to the measured 
0.0. at 405 nm. Competition was estimated by the ad-
ditivity of the absorbance values as described elsewhere 
(Friguet et aI., 1983). 
Furthermore, the supernatants were tested by a di-
rect ELlS A (Linington et aI., 1992) for their reactivity 
with small synthetic peptide sequences spanning the en-
tire extracellular domain of PO: peptide 56-71 from rat 
PO and peptides 1-20, 19-38,38-56,70-85,84-110, 
98-116, and 115-126 from bovine PO. The numbering 
sequence refers to the mature protein sequence. 
Isotype Determination of Monoclonal Antibodies 
Antibody isotypes were determined by ELISA us-
ing Ig-subclass-specific poly clonal rabbit-anti-mouse an-
tibodies followed by goat-anti-rabbit Ig antibodies con-
jugated to horseradish peroxidase (Biorad, Munich, 
Germany). 
Preparation of Myelin From Sciatic Nerves 
Myelin from human, rat, mouse, and bovine PNS 
and CNS was prepared according to the method of Uye-
mura et al. (1972). Fresh bovine nervous tissue was ob-
tained from the local slaughterhouse and human sciatic 
nerves from autopsies carried out at the Oepartment of 
Pathology, University of Wiirzburg. 
SOS-PAGE and Western Blot Analysis 
SOS-PAGE was carried out on 10% and 15% acry-
lamide containing gels according to the method of Laem-
mli (1970). Proteins were stained with Coomassie blue. 
Western blot analysis was performed according to the 
method of Towbin et al. (1979), with minor modifica-
tions. Then 2 f-Lg of PO-EO or 5 f-Lg of myelin (human, 
rat, mouse, bovine) were loaded on to each lane. After 
SOS-PAGE, proteins were transferred electrophoreti-
cally to nitrocellulose membranes (Schleicher und 
Schiill, Oassel, Germany) at 80 mA for 2 hr. Unreactive 
binding sites were saturated for 2 hr with 30% FCS (Bio-
chrom, Berlin, Germany) and 3% BSA. The nitrocellu-
lose strips were then washed with PBS, pH 8.0, and 
0.1 % Tween, and incubated in sequence with hybridoma 
culture supernatants overnight at 4°C and, after washing, 
with alkaline-phosphatase coupled rabbit-anti-mouse Ig 
(Boehringer, Mannheim, Germany, diluted 1: 500) for 
another 60 min. 
Nitrocellulose membranes were stained with NBT 
(para-nitrotetrazolium blue) and BCIP (5-bromo-4-
chloro-3-indolylphosphate, Sigma, Munich, Germany), 
diluted in alkaline phosphatase buffer (lOO mM Tris-
HCl, 100 mM NaCl 5 mM MgCl, pH 9.4). Polyclonal 
rabbit-anti-PO-EO (final dilution 1: 1 ,000) was used as a 
positive control and for internal standardization. 
Immunohistochemistry 
For immunohistochemical investigations, human 
and rat sciatic nerve and brain sections were studied us-
ing the streptavidin-biotin-peroxidase complex technique 
(Scheidt and Friede, 1987). Human and rat sciatic nerve 
were frozen without prior fixation in isopentane, cut into 
10 f-Lm sections on a Leitz cryostat, and air-dried for 45 
min at room temperature. After fixation in acetone at 
-20°C for 10 min, the sections were blocked with 30% 
porcine serum (obtained from Sigma) to reduce nonspe-
cific staining and were incubated overnight at 4°C with 
undiluted hybridoma culture supernatant. Sections were 
washed, incubated with 0.5% hydrogen peroxide in 
methanol 15 min at room temperature to block endoge-
nous peroxidase activity, and then the biotinylated sec-
ond antibody [sheep-anti-mouse immunoglobulin, 
F(ab'}z fragments] preabsorbed with rat serum was ap-
plied for 30 min. Finally the peroxidase reaction product 
was developed with 0.05% diaminobenzidine and 0.01 % 
hydrogen peroxide in PBS for 10 min. 
For paraffin embedding tissue was fixed overnight 
in 4% paraformaldehyde as previously described (lung et 
aI., 1992). Staining on paraffin-embedded sections of 5 
f-Lm was performed as described above. In order to dem-
onstrate the specificity of the staining, monoclonal anti-
bodies were absorbed with a 10-fold excess of PO-EO (on 
a molar basis) for 30 min at 37°C before staining. 
RESULTS 
Selection of Monoclonal Antibodies 
Selection of suitable hybridoma clones was done 
by using the ELISA technique. All the supernatants were 
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TABLE I. Summary of Reaction Pattern of POl-P07 in Western Blot 
and Immunohistochemistry 
Western blot Histochemistry 
Antibody Ig class PO-EO PO-rat PO-human Rat Human 
POI IgM + 
P02 IgM + 
P03 IgG3 + 
P04 IgM + + + 
POS IgM + + + + + 
P06 IgM + + + + + 
P07 IgGI + + + + + 
All antibodies were tested for their reactivity with recombinant PO-EO, and human and rat PO, with 
Western blot and by immunohistochemistry. The antibodies POI-P07 all reacted with PO-EO, but 
only 4 of them (P04-P07) recognized human or rat PO. Antibodies with the same reaction pattern 
were further characterized in a competition and direct ELISA using synthetic peptides. 
tested for reactivity with PO-ED in the ELISA. From the 
first fusion, 16 hybridoma supernatants were obtained 
that gave a positive result in this test. These selected 
supernatants were further evaluated for their reactivity 
with whole-rat myelin in the ELISA. Only 4 of the 16 
selected antibodies gave a positive signal, indicating that 
they not only recognize recombinant PO-ED but also na-
tive PO of the rat. These 4 monoclona1 antibodies were 
designated P04-P07, and 3 of the remaining group giv-
ing rise to the highest absorbance values in the ELISA 
with PO-ED were designated P01-P03. The 7 mono-
clonal antibodies were then further characterized with 
Western blot, competition, and direct ELISA, and by 
immunohistochemistry. The other 9 antibodies were not 
studied further. 
Antigenic Specificity and Species Distribution of 
POt-P07 
Antigen specificity and species distribution of PO 1-
P07 were analysed by Western blot. The results are sum-
marized in Table 1. All of the 7 selected antibodies rec-
ognized a single band with an apparent molecular mass 
of approximately 17 kD in the Western blot, correspond-
ing to PO-ED (Fig. 1, lanes 1 and 4). 
When rat and human myelin proteins were blotted, 
supernatants POl-P03 failed to recognize PO. Only P05-
P07 reacted with whole native rat and human PO banding 
at 29 kD (Fig. 1), thus confirming the results obtained in 
the ELISA using myelin. Interestingly, P04 only reacted 
with rat PO but not with human PO (Fig. 1). P04-P07 
also recognized mouse PO but failed to react with bovine 
PO in the Western blot (data not shown). No other pe-
ripheral myelin proteins, including MBP or P2, were 
detected with these antibodies, nor did they recognize 
myelin proteins from the rat or human central nervous 
system in the Western blot, thus establishing their spec-
ificity for PO. 
In most myelin preparations, one band with a mo-
lecular weight of 29 kD was exclusively detected. In a 
few myelin preparations, a further band at 24 kD was 
detected, probably representing a degradation product of 
PO. Its appearance was variable and not species depen-
dent. This observation may be attributed to the presence 
of proteases in the myelin preparation (see below). 
Immunocytochemistry 
Immunohistochemical studies on frozen and paraf-
fin-embedded sections of adult human and rat nervous 
tissue revealed that the antibodies P04-P07 bound spe-
cifically to human or rat peripheral nerve myelin (Table 
I). In the paraffin-embedded sections the immunoreac-
tivity was exclusively localized in compacted myelin 
sheaths, whereas the axonal cytoplasm and capillary en-
dothelial cells were completely spared (Fig. 2). 
Staining of frozen sections revealed the same reac-
tion pattern of antibodies P04-P07 as in the paraffin 
sections. However, in the frozen sections staining was 
less intense and background staining was higher, result-
ing in less contrast when compared to the paraffin sec-
tions (data not shown). Preabsorption of the monoclonal 
antibodies with PO-ED resulted in complete loss of stain-
ing, indicating that staining of PO was specific. No stain-
ing was observed in sections of human and rat brain (data 
not shown). 
Epitope Specificity of POt-P07 
POI-P03 and POS-P07 antibodies exhibited a sim-
ilar reaction pattern in the ELISA, Western blot, and by 
immunohistochemistry (Table I). To investigate whether 
these monoclonal antibodies were reactive to the same or 
to independent epitopes, competition and direct ELISAs 
were performed. 
The results obtained with the competition ELISA 
are summarized in Table 11. The theoretical sum of re-
activities of POI and P02 at saturation levels is 0.74, 
which is reached approximately by the experimental 
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Fig . I. Immunostaining of peripheral nerve myelin and PO-ED 
by the monoclonal antibodies P07 (lanes 1-3) and P04 (lanes 
4-6) in Western blots . Lanes I and 4 correspond to PO-ED, 
lanes 2 and 5 correspond to human myelin , and lanes 3 and 6 
value of 0.64 and indicates that each antibody binds to a 
different and distant epitope. The values of absorbance 
obtained with pas and P06 when added together (0.21) 
were significantly below their singular values (0.S9 and 
0.41) , indicating that both antibodies bind to epitopes in 
close vicinity and that the large IgM molecules exert 
steric hinderance on each other. 
When tested in a direct ELISA only 2 of the anti -
bodies, pas and P06, were found to react with any of the 
panel of overlapping synthetic PO peptides listed in the 
text previously. Interestingly, although both antibodies 
recognized an epitope within the same peptide pS6-7l, 
they differ markedly with respect to their binding relative 
to PO-EO (Table Ill). This confirmed the observation 
made in the competition ELISA test that pas and P06 
bind to 2 different nearby epitopes. The other S mono-
clonal antibodies, POI-P04 and P07, also reactive with 
whole PO-EO, displayed no reactivity to any of the tested 
sequences. 
DISCUSSION 
We have described and characterized 7 monoclonal 
antibodies, POI-P07, which recognize the extracellular 
domain of human, rat, and mouse PO. The antibodies 
appear to react with different epitopes of the protein 
backbone of PO , as concluded from their recognition pat-
29~ 
17~ 
4 5 6 
correspond to rat myelin . Note the presence of a 24-kD PO 
band, possibly a cleavage product , in the rat myelin prepara-
tion . Arrows on the left indicate the molecular mass in kilodal -
tons. 
terns in Western blot, immunohistochemistry, and com-
petition or direct ELISA with synthetic peptides. 
pal and P02 clearly react with different epitopes, 
as evidenced in the competition ELISA. P03 and P07 had 
to be excluded from the competition assay , as their 19 
classes differ from the others. In the same assay addition 
of both pas and P06 together showed a significant re-
duction of absorbance . Such a reduced value can be ob-
tained with antibodies of the IgM class if both bind 2 
epitopes in close proximity . The direct ELISA with these 
2 antibodies confirmed that they bind to nearby epitopes: 
The binding of pas and P06 to the peptide pS6-71 dif-
fered considerably when compared to their ability to bind 
to PO-EO in a direct ELISA. This difference suggests 
that the 2 monoclonal antibodies recognize spatially 
close but dissimilar epitopes within the neuritogenic 
amino acid sequence S6-71 of the extracellular domain 
of PO. The low binding of pas to the peptide may indi-
cate that conformation of the epitope is altered in the 
peptide, relative to that in PO-EO, or alternatively, the 
interaction between the peptide and plastic surface of the 
ELISA plate interferes with antibody binding. 
The other S monoclonal antibodies, POl-P04 and 
P07, failed to bind to any peptide sequence tested, prob-
ably because most of the sequences of PO used were of 
bovine origin. The protein sequence of bovine PO-EO 
differs from human PO-EO in 7 and from rat PO-EO in 6 
Fig. 2. Immunohistochemical characterization of P07 mono-
clonal antibody. Sciatic nerve from rat was fixed overnight in 
4% paraformaldehyde, embedded in paraffin, and sections (5 
f.lm) were stained by the streptavidin-biotin-peroxidase tech-
TABLE II. Results of the Competition ELlSA Test for the 




POI + P02 
POS 
P06 
POS + P06 
0.0. (40S nm) 
0 .36 ± 0.02 
0.38 ± O.OS 
0 .64 ± 0.02 
0.S9 ± 0.04 
0.41 ± 0.02 




Hybridoma supernatants of each antibody were combined as indicated 
and added to microtiter plates coated with PO-EO. The resulting bind-
ing was visualized (see Materials and Methods) and quantified by 
reading the optical density (0.0.) at 40S nm. Results are means ± 
standard deviation of the 0.0. from 2 independent experiments done 
in quadruplicate. P03 and P07 were not included in this test because 
they were not of the IgM isotype. 
amino acid residues (Lemke and Axel, 1985; Sakamoto 
et ai., 1987; Ilayasaka et aI., 1991). This explains the 
lack of recognition of the peptides used and of total bo-
vine PO in the Western blot. 
Furthermore, it is well known that small peptides 
often differ from the whole protein in their 3-dimensional 
structure and, in consequence, also in their antigenicity. 
They sometimes even escape detection by specific anti-
bodies in ELISA, as short epitopes may be masked by 
adherence to the ELlS A plate. This last point is con-
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nique . Specific staining of myelin sheaths (arrow) of the pe-
ripheral nerves is seen. Axonal cytoplasma (asterisk) or capil-
lary endothelial cells (arrowhead) are not labeled. Background 
staining is very low. Magnification: x 440. 
T ABLE Ill. Monoc1onal Antibodies POS and P06 Recognize the 
Neuritogenic Determinant of Rat PO 
Monoclonal antibody 
Coating antigen POS P06 
PO-EO 1.7S ± 0.14 2.90±0.16 
pS6-7 1 0.68 ± 0.07 0.44 ± 0.03 
BSA 0.16 ± 0.09 0.21 ± 0.08 
Ratio PO-EO/pS6-71 3.06 11 .69 
Culture supernatants obtained from all 16 clones were tested by 
ELlSA for reactivity with PO-EO and the synthetic PO peptides listed 
in Materials and Methods. Only the monoclonal antibodies POS and 
P06 exhibited reactivity with both PO-EO and a peptide, each recog-
nizing an epitope within the amino acid sequence residues S6-7 1 of rat 
PO . However, binding to the peptide was considerably weaker than 
that observed for PO-EO, being most marked for P06 . Results are 
expressed as the mean values ± standard deviation of optical density 
at 40S nm obtained from triplicate wells. These values are not cor-
rected for the background against BSA , which is listed separately. The 
second peroxidase conjugated anti-mouse antibody did not bind to 
either PO-EO or any of the synthetic peptides. 
firmed by the much lower 0 .0 . values detected with P05 
and P06 using peptide-coated plates, compared to the 
absorbance values recorded when total PO-EO is used at 
the same molar concentration (Table III). 
P07 showed the same reaction pattern in Western 
blot and immunohistochemistry as P05 and P06 , but it 
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was negative in the direct ELISA test, indicating binding 
to a different epitope. P04 must react with a different 
epitope than the other 6 antibodies, because it 
recognized only rat PO, but not huma'l PO in the Western 
blot. 
In the Western blot of rat myelin, the antibodies 
occasionally recognized a protein with an apparent mo-
lecular mass of 24 kD, besides the native PO. This was 
assumed to be a PO degradation product. Recently it has 
been shown that rat PO is cleaved by proteases present in 
myelin of the peripheral nervous system, resulting in a 
24 kD PO molecule (Agrawal et aI., 1990; Van den Berg 
et aI., 1990). Thus the protein stained in some myelin 
preparations in our experiments could be such a cleavage 
product. In conclusion, we show that the selected anti-
bodies react with different epitopes of PO-ED, although 
only the epitopes recognized by P05 and P06 could be 
defined in terms of amino acid sequence. 
The other 9 antibodies selected initially by ELISA 
were not further characterized in this study, because they 
gave a positive result with PO-ED in the ELISA and 
Western blot but could not detect mammalian PO in the 
tests used. Therefore they either recognize the pET-de-
rived sequences of PO-ED, or PO epitopes which are not 
accessible to them in the native PO molecule. These con-
formational differences of PO-ED and native PO could be 
due to the lack of carbohydrate moieties on the recom-
binant form of PO. 
In the past, several groups have produced antibod-
ies to PO (Franko et al. 1982; Miller et al. 1984; Bol-
lensen et aI., 1990). Antibodies 592 and 593 (a generous 
gift from Dr. M. Schachner, Department of Neurobiol-
ogy, ETH, Zurich, Switzerland), described by Bollensen 
et al. (1990), were also used in our assays and were 
compared to our antibodies. In contrast to the antibodies 
PO I-P07, they did not react with the extracellular do-
main of PO in Western blot or ELISA (data not shown). 
The main advantage of PO I-P07 is their ability to 
recognize different partially defined epitopes of the ex-
tracellular domain of PO. P05-P07 react with mouse, rat, 
and human PO, indicating that they bind to epitopes 
which are highly conserved and might be of functional 
importance. 
Antibodies to PO are found during neuropathies as-
sociated with monoclonal gammopathies (Steck and 
Schluep, 1989; Hartung et aI., 1992; Toyka and Hartung, 
1992). Most of the antibodies described are directed 
against oligosaccharide residues on PO and are thought to 
be responsible for the failure of myelin compaction ob-
served in some of the neuropathies in these patients. 
Furthermore, there is evidence that antibodies directed to 
the protein backbone of the extracellular domain of PO 
are present during experimental autoimmune ("aller-
gic") neuritis (EAN) and the Guillain-Barre syndrome 
(GBS; RAC Hughes, London, personal communication, 
and our own unpublished observations). 
Currently we are using the antibodies POl-P07 in a 
sandwich ELlS A to detect PO-ED-like immunoreactivity 
in serum and cerebrospinal fluid during GBS and its 
animal model EAN (Archelos et aI., 1993). Interest-
ingly, recombinant PO-ED is not neuritogenic in suscep-
tible Lewis rats or rabbits, although the neuritogenic se-
quence alone contained in PO-ED (amino acid residues 
56-71) is a strong neuritogen in both species (our own 
unpublished observations). 
We believe that these monoclonal antibodies will 
be useful tools to investigate the role of PO during my-
elination and in demyelinating diseases. 
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